State Contract Pharmacy Lawsuit Roundup: Updates in Utah, Rhode Island, Colorado, Nebraska

Key briefs were filed recently in litigation over state 340B contract pharmacy laws in Utah, Rhode Island, Colorado and Nebraska.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Continue Reading

PhRMA Sues South Dakota, Maine Over 340B Contract Pharmacy Access Laws

South Dakota's recently enacted law barring manufacturer contract pharmacy restrictions is facing its third drug industry lawsuit in federal court.

The Pharmaceutical Research and Manufacturers of America (PhRMA) recently filed two new lawsuits challenging 340B contract pharmacy access laws in [...]

Continue Reading

News Alert

Federal Court Rejects Drugmakers’ Bid to Block Maine’s 340B Contract Pharmacy Law, One Day Before It Takes Effect

Maine can enforce its recently enacted 340B contract pharmacy access law while drug industry litigation plays out, a federal judge ruled yesterday.

A federal district judge yesterday cleared the way for Maine to begin enforcing its 340B contract pharmacy law, ruling against [...]

Continue Reading

Bausch Health Removes High-Cost Liver Disease, GI Treatment, Many Other Drugs From 340B and Medicaid Rebate Programs

Bausch Health will remove several drugs from the 340B and Medicaid rebate programs effective Oct. 1.

340B hospitals looking to use Xifaxan could soon have to pay thousands for the commonly used hepatic encephalopathy and irritable [...]

Continue Reading

Stakeholders Back CMS’ 340B Data Repository Plan for Medicare Part D, Differ Sharply on Implementation

CMS' plan for a 340B data repository drew support from 340B stakeholders, but they disagreed sharply on its implementation.

Providers and drugmakers are aligned on the government’s plan to build a new 340B claims data repository for Medicare Part [...]

Continue Reading

Michigan House Committee to Debate 340B Contract Pharmacy and Reporting Bill After Senate Passed Similar Measure

The Michigan House Health Policy Committee is holding a Sept. 24 hearing on a 340B bill with contract pharmacy access and reporting provisions.

A Michigan House committee tomorrow will debate a provider-backed 340B contract pharmacy access bill with both hospital and manufacturer reporting [...]

Continue Reading

Federal Court Sets Mid-November Oral Arguments for Drugmakers’ 340B Rebate Appeals

A Washington, D.C. federal appeals court scheduled Nov. 17 oral arguments in the drug industry's 340B rebate appeal.

A federal appeals court in Washington, D.C. has rescheduled oral arguments for Nov. 17 in the drug industry’s high-stakes litigation [...]

Continue Reading

Wall Street Journal Editorial Takes Aim at 340B Program, PhRMA Touts Op-Ed

The Wall Street Journal’s editorial board called for major 340B program overhauls in a Sept. 21 op-ed.

An influential newspaper’s editorial board recently called for major overhauls to the 340B program, arguing in a new editorial that [...]

Continue Reading

CMS Begins Contacting Hospitals About Drug Cost Survey Likely Tied to Future 340B Medicare Cuts

The Centers for Medicare & Medicaid Services is reaching out to hospital staff regarding its upcoming Medicare acquisition cost survey.

The Centers for Medicare & Medicaid Services (CMS) has begun reaching out to hospitals about an upcoming drug acquisition cost [...]

Continue Reading
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live

Sliding Sidebar

Link to spotlight on Sean Hall of Visante

Article Archives